Type 1 Diabetes (T1D) Market Report

China Type 1 Diabetes (T1D) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 23, 2022
  • PAGES：178
  • REPORT CODE：GMM1114337
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Type 1 Diabetes (T1D) market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Type 1 Diabetes (T1D) market. Detailed analysis of key players, along with key growth strategies adopted by Type 1 Diabetes (T1D) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Lexicon

    • Merck

    • Boehringer Ingelheim

    • Janssen

    • Astellas

    • Sanofi

    • Samsung Bioepis

    • Bristol-Myers Squibb

    • Novo Nordisk

    • Eli Lilly

    • Biocon

    By Type:

    • Rapid Acting Insulin Analogs

    • Long Acting Insulin Analogs

    • Premix Insulin Analogs

    By End-User:

    • Children

    • Adults

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Type 1 Diabetes (T1D) Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Type 1 Diabetes (T1D) Market Size and Growth Rate of Rapid Acting Insulin Analogs from 2016 to 2027

    • 1.3.2 China Type 1 Diabetes (T1D) Market Size and Growth Rate of Long Acting Insulin Analogs from 2016 to 2027

    • 1.3.3 China Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Type 1 Diabetes (T1D) Market Size and Growth Rate of Children from 2016 to 2027

    • 1.4.2 China Type 1 Diabetes (T1D) Market Size and Growth Rate of Adults from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Type 1 Diabetes (T1D) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Type 1 Diabetes (T1D) by Major Types

    • 3.4.1 Market Size and Growth Rate of Rapid Acting Insulin Analogs

    • 3.4.2 Market Size and Growth Rate of Long Acting Insulin Analogs

    • 3.4.3 Market Size and Growth Rate of Premix Insulin Analogs

    4 Segmentation of Type 1 Diabetes (T1D) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Type 1 Diabetes (T1D) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Type 1 Diabetes (T1D) in Children

    • 4.4.2 Market Size and Growth Rate of Type 1 Diabetes (T1D) in Adults

    5 Market Analysis by Regions

    • 5.1 China Type 1 Diabetes (T1D) Production Analysis by Regions

    • 5.2 China Type 1 Diabetes (T1D) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Type 1 Diabetes (T1D) Landscape Analysis

    • 6.1 North China Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 6.2 North China Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    7 Central China Type 1 Diabetes (T1D) Landscape Analysis

    • 7.1 Central China Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 7.2 Central China Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    8 South China Type 1 Diabetes (T1D) Landscape Analysis

    • 8.1 South China Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 8.2 South China Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    9 East China Type 1 Diabetes (T1D) Landscape Analysis

    • 9.1 East China Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 9.2 East China Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    10 Northeast China Type 1 Diabetes (T1D) Landscape Analysis

    • 10.1 Northeast China Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 10.2 Northeast China Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    11 Southwest China Type 1 Diabetes (T1D) Landscape Analysis

    • 11.1 Southwest China Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 11.2 Southwest China Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    12 Northwest China Type 1 Diabetes (T1D) Landscape Analysis

    • 12.1 Northwest China Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 12.2 Northwest China Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Lexicon

      • 13.1.1 Lexicon Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Merck

      • 13.2.1 Merck Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Boehringer Ingelheim

      • 13.3.1 Boehringer Ingelheim Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Janssen

      • 13.4.1 Janssen Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Astellas

      • 13.5.1 Astellas Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Sanofi

      • 13.6.1 Sanofi Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Samsung Bioepis

      • 13.7.1 Samsung Bioepis Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Bristol-Myers Squibb

      • 13.8.1 Bristol-Myers Squibb Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Novo Nordisk

      • 13.9.1 Novo Nordisk Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Eli Lilly

      • 13.10.1 Eli Lilly Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Biocon

      • 13.11.1 Biocon Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Type 1 Diabetes (T1D) Market Size and Growth Rate of Rapid Acting Insulin Analogs from 2016 to 2027

    • Figure China Type 1 Diabetes (T1D) Market Size and Growth Rate of Long Acting Insulin Analogs from 2016 to 2027

    • Figure China Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Type 1 Diabetes (T1D) Market Size and Growth Rate of Children from 2016 to 2027

    • Figure China Type 1 Diabetes (T1D) Market Size and Growth Rate of Adults from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Type 1 Diabetes (T1D) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Type 1 Diabetes (T1D) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Type 1 Diabetes (T1D)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Type 1 Diabetes (T1D) by Different Types from 2016 to 2027

    • Table Consumption Share of Type 1 Diabetes (T1D) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Rapid Acting Insulin Analogs

    • Figure Market Size and Growth Rate of Long Acting Insulin Analogs

    • Figure Market Size and Growth Rate of Premix Insulin Analogs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Type 1 Diabetes (T1D) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Type 1 Diabetes (T1D) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Children

    • Figure Market Size and Growth Rate of Adults

    • Table China Type 1 Diabetes (T1D) Production by Regions

    • Table China Type 1 Diabetes (T1D) Production Share by Regions

    • Figure China Type 1 Diabetes (T1D) Production Share by Regions in 2016

    • Figure China Type 1 Diabetes (T1D) Production Share by Regions in 2021

    • Figure China Type 1 Diabetes (T1D) Production Share by Regions in 2027

    • Table China Type 1 Diabetes (T1D) Consumption by Regions

    • Table China Type 1 Diabetes (T1D) Consumption Share by Regions

    • Figure China Type 1 Diabetes (T1D) Consumption Share by Regions in 2016

    • Figure China Type 1 Diabetes (T1D) Consumption Share by Regions in 2021

    • Figure China Type 1 Diabetes (T1D) Consumption Share by Regions in 2027

    • Table North China Type 1 Diabetes (T1D) Consumption by Types from 2016 to 2027

    • Table North China Type 1 Diabetes (T1D) Consumption Share by Types from 2016 to 2027

    • Figure North China Type 1 Diabetes (T1D) Consumption Share by Types in 2016

    • Figure North China Type 1 Diabetes (T1D) Consumption Share by Types in 2021

    • Figure North China Type 1 Diabetes (T1D) Consumption Share by Types in 2027

    • Table North China Type 1 Diabetes (T1D) Consumption by End-Users from 2016 to 2027

    • Table North China Type 1 Diabetes (T1D) Consumption Share by End-Users from 2016 to 2027

    • Figure North China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2016

    • Figure North China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2021

    • Figure North China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2027

    • Table Central China Type 1 Diabetes (T1D) Consumption by Types from 2016 to 2027

    • Table Central China Type 1 Diabetes (T1D) Consumption Share by Types from 2016 to 2027

    • Figure Central China Type 1 Diabetes (T1D) Consumption Share by Types in 2016

    • Figure Central China Type 1 Diabetes (T1D) Consumption Share by Types in 2021

    • Figure Central China Type 1 Diabetes (T1D) Consumption Share by Types in 2027

    • Table Central China Type 1 Diabetes (T1D) Consumption by End-Users from 2016 to 2027

    • Table Central China Type 1 Diabetes (T1D) Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2016

    • Figure Central China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2021

    • Figure Central China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2027

    • Table South China Type 1 Diabetes (T1D) Consumption by Types from 2016 to 2027

    • Table South China Type 1 Diabetes (T1D) Consumption Share by Types from 2016 to 2027

    • Figure South China Type 1 Diabetes (T1D) Consumption Share by Types in 2016

    • Figure South China Type 1 Diabetes (T1D) Consumption Share by Types in 2021

    • Figure South China Type 1 Diabetes (T1D) Consumption Share by Types in 2027

    • Table South China Type 1 Diabetes (T1D) Consumption by End-Users from 2016 to 2027

    • Table South China Type 1 Diabetes (T1D) Consumption Share by End-Users from 2016 to 2027

    • Figure South China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2016

    • Figure South China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2021

    • Figure South China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2027

    • Table East China Type 1 Diabetes (T1D) Consumption by Types from 2016 to 2027

    • Table East China Type 1 Diabetes (T1D) Consumption Share by Types from 2016 to 2027

    • Figure East China Type 1 Diabetes (T1D) Consumption Share by Types in 2016

    • Figure East China Type 1 Diabetes (T1D) Consumption Share by Types in 2021

    • Figure East China Type 1 Diabetes (T1D) Consumption Share by Types in 2027

    • Table East China Type 1 Diabetes (T1D) Consumption by End-Users from 2016 to 2027

    • Table East China Type 1 Diabetes (T1D) Consumption Share by End-Users from 2016 to 2027

    • Figure East China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2016

    • Figure East China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2021

    • Figure East China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2027

    • Table Northeast China Type 1 Diabetes (T1D) Consumption by Types from 2016 to 2027

    • Table Northeast China Type 1 Diabetes (T1D) Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Type 1 Diabetes (T1D) Consumption Share by Types in 2016

    • Figure Northeast China Type 1 Diabetes (T1D) Consumption Share by Types in 2021

    • Figure Northeast China Type 1 Diabetes (T1D) Consumption Share by Types in 2027

    • Table Northeast China Type 1 Diabetes (T1D) Consumption by End-Users from 2016 to 2027

    • Table Northeast China Type 1 Diabetes (T1D) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2016

    • Figure Northeast China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2021

    • Figure Northeast China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2027

    • Table Southwest China Type 1 Diabetes (T1D) Consumption by Types from 2016 to 2027

    • Table Southwest China Type 1 Diabetes (T1D) Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Type 1 Diabetes (T1D) Consumption Share by Types in 2016

    • Figure Southwest China Type 1 Diabetes (T1D) Consumption Share by Types in 2021

    • Figure Southwest China Type 1 Diabetes (T1D) Consumption Share by Types in 2027

    • Table Southwest China Type 1 Diabetes (T1D) Consumption by End-Users from 2016 to 2027

    • Table Southwest China Type 1 Diabetes (T1D) Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2016

    • Figure Southwest China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2021

    • Figure Southwest China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2027

    • Table Northwest China Type 1 Diabetes (T1D) Consumption by Types from 2016 to 2027

    • Table Northwest China Type 1 Diabetes (T1D) Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Type 1 Diabetes (T1D) Consumption Share by Types in 2016

    • Figure Northwest China Type 1 Diabetes (T1D) Consumption Share by Types in 2021

    • Figure Northwest China Type 1 Diabetes (T1D) Consumption Share by Types in 2027

    • Table Northwest China Type 1 Diabetes (T1D) Consumption by End-Users from 2016 to 2027

    • Table Northwest China Type 1 Diabetes (T1D) Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2016

    • Figure Northwest China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2021

    • Figure Northwest China Type 1 Diabetes (T1D) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Lexicon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lexicon

    • Figure Sales and Growth Rate Analysis of Lexicon

    • Figure Revenue and Market Share Analysis of Lexicon

    • Table Product and Service Introduction of Lexicon

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Samsung Bioepis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Bioepis

    • Figure Sales and Growth Rate Analysis of Samsung Bioepis

    • Figure Revenue and Market Share Analysis of Samsung Bioepis

    • Table Product and Service Introduction of Samsung Bioepis

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US